Ascendis Pharma A/S (ASND)
225.00
-5.21
(-2.26%)
USD |
NASDAQ |
Feb 20, 16:00
225.74
+0.74
(+0.33%)
After-Hours: 20:00
Ascendis Pharma Shareholders Equity (Quarterly) : -191.23M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 30.51B |
| Evaxion AS | 10.34M |
| DBV Technologies SA | 52.85M |
| Cellectis SA | 100.48M |
| Biodexa Pharmaceuticals Plc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.530B |
| Total Liabilities (Quarterly) | 1.721B |
| Debt to Equity Ratio | -5.354 |
| Current Ratio | 1.037 |
| Net Debt Paydown Yield | -0.22% |